New shot aims to boost energy in rare Muscle-Wasting diseases
Disease control
Completed
This study tested whether a daily injection called elamipretide could help adults with a specific type of genetic mitochondrial disease that causes muscle weakness and fatigue. About 102 participants received either the drug or a placebo for 48 weeks. Researchers measured changes…
Phase: PHASE3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC